echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Eur Radiol: Can bone marrow ADC values guide clinical prediction of prognosis in patients with multiple myeloma?

    Eur Radiol: Can bone marrow ADC values guide clinical prediction of prognosis in patients with multiple myeloma?

    • Last Update: 2021-02-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Multiple myeloma (MM) is an incurable malignant tumor of the blood system.
    the risk of disease progress and death is important for early identification of high-risk patients who require different treatment strategies.
    a number of risk strated models have been proposed, some high-risk patients have not been identified.
    for newly diagnosed MMs, a new model is needed to improve the risk layering approach.
    bone lesions are an important feature of MM and have strong diagnostic and prognostic value.
    magnetic resonance (especially systemic MRI) has high sensitivity to the display of nervous system and soft tissue, more accurate display of normal and tumor-soaked bone marrow, and no radiation.
    systemic diffusion-weighted MRI (WB DW-MRI) imaging is a functional MR imaging that quantifies disease levels and therapeutic responses.
    the surface diffusion coefficient (See diffusion coefficient, ADC) value is an important quantitative parameter described by DW-MRI.
    , a recent study published in the journal European Radiology examined the relationship between baseline WB DW-MRI parameters (including ADC values) and progress-free lifetime (PFS) and total lifetime (OS) in newly diagnosed MM patients, clarifying the prognostic value of ADC (esoteric dispersion coefficient) as an important quantitative parameter for dispersive weighted MRI for multiple myeloma (MM).
    this study is a forward-looking single-center study that includes 114 consecutive newly diagnosed MM patients, each with a full-body dispersion weighted MRI (WB DW-MRI) scan at the baseline.
    clinical and MRI parameters when using single-factor and multi-factor methods to analyze baselines to determine independent risk factors for progress-free lifetime (PFS) and total lifetime (OS).
    five different DW-MRI types were observed, with a representative background bone marrow ADC value averaging 0.4662 ± 0.1939 × 10-3 mm2/s.
    50.2 months of follow-up (range 15.7-75.8 months), 24 patients died and 7 lost follow-up.
    representative background bone marrow ADC value is PFS (HR 4.664; 95% confidence interval (CI) 1.138-19.121; p - 0.032) and total survival rate (HR 14.130; 95% confidence interval 1.544 - -129.299; p - 0.019) independent risk factor.
    when using single-factor analysis, DW-MRI shows a normal/pepper-salt-type correlation with PFS (p s 0.035), but there is no statistical correlation in multi-factor Cox regression analysis.
    FS(a) and OS(b) survival curves, which represent a truncated value of 0.45×10-3 mm2/s for patients with different DW-MRI models of PFS(a) and OS(b) survival curve bone marrow ADC average predictive multiple myeloma PFS and OS, indicating that DW-MRI has a predictive role in the risk stratation of new MM patients at baseline.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.